Beckman Coulter Access Sex Hormone Binding Globulin (SHBG) assay

Friday, 20 November, 2009 | Supplied by: Beckman Coulter Australia

Beckman Coulter has expanded its reproductive disease state management range with the Access Sex Hormone Binding Globulin (SHBG) assay for use in the differential diagnosis of conditions of chronic or excessive androgenic activity. The assay may also be used in conjunction with the Access Testosterone Assay to provide a calculated free androgen index1.

Access reproductive solutions are part of a comprehensive assay menu featured on Access and UniCel Immunoassay Systems, including the i class family of integrated systems: UniCel DxC 880i, UniCel DxC 660i, UniCel DxC 680i, UniCel DxC 860i and UniCel 600i.

Online: www.beckman.com.au
Phone: 1800 060 878
Related Products

Invent Biotechnologies Minute Single Cell Nuclei Kits

The Invent Biotechnologies Minute Single Cell Nuclei Kits use proprietary spin column-based...

MP Biomedicals MagBeads FastDNA MaxPure Kit for Feces and Fecal Preservation Solution

MP Biomedicals MagBeads FastDNA MaxPure Kit for Feces is a magnetic bead-based solution...

Enzo Life Sciences Histamine ELISA Kit

The Enzo Life Sciences Histamine ELISA Kit is engineered to enable the ultra-sensitive detection...

Content from other channels on our network

WA Government commits $6.5m in funding to local space research

Steelmaking returning to Newcastle with Greensteel Australia

ABB announces AI‍-‍powered autonomous forklift

AMCRC announces project to evaluate local titanium powder

NSW to invest $12bn to rebuild Hunter train manufacturing

Analysis shows AI's water use demands immediate action

New method recycles mixed plastic packaging sans chemicals

Engineers extract lithium using low-water alternative

Microbubbles remove microplastics from wastewater

Partnership boosts bio-based graphite material deployment

Why cyber resilience is now a patient safety KPI

Woman fined for falsely claiming to be a psychologist in ACT Supreme Court

Training suite simulates hospital, aged care and community health settings

National standards for pain management education now available

Daniel Wyner appointed Lumary CEO

  • All content Copyright © 2026 Westwick-Farrow Pty Ltd